The management of clinical trial distribution has changed very much as a result of changes in the wider pharmaceutical industry. Martin Lamb of Biotec Services International discusses how this service has developed, and drivers for some of the change. While the management of the clinical supply chain is a critical part of drug development, it can be viewed as a high-cost, low-value-adding component of drug development for a pharma company to take on single-handed. But external clinical supply specialists, by spreading this cost over multiple sponsors, have been able to invest in improving distribution models to provide a truly global clinical trial supply chain.
https://international-pharma.com/wp-content/uploads/2014/10/Clinical-Trial.pdf